{Reference Type}: Journal Article
{Title}: Multidrug resistance: The clinical dilemma of refractory Helicobacter pylori infection.
{Author}: Kuo CJ;Lee CH;Chang ML;Lin CY;Lin WR;Su MY;Chiu CH;Tseng CN;Wu YS;Chiu CT;Lai CH;
{Journal}: J Microbiol Immunol Infect
{Volume}: 0
{Issue}: 0
{Year}: Mar 2021 23
{Factor}: 10.273
{DOI}: 10.1016/j.jmii.2021.03.006
{Abstract}: This study investigated the antimicrobial resistance of isolates from patients with refractory Helicobacter pylori. The resistance rate was 34.1% for amoxicillin, 92.7% for clarithromycin, 65.9% for metronidazole, 85.4% for levofloxacin, and 29.3% for rifabutin. Dual resistance to both clarithromycin and levofloxacin was found in 73.2%. The antimicrobial resistance rate of refractory H. pylori was extremely high, which had become a major consideration in therapeutic challenge.